June 9, 2020 / 11:39 AM / a month ago

BRIEF-Thermo Fisher To Co-Develop A Global Companion Diagnostic For Low-Grade Glioma With Agios Pharmaceuticals

June 9 (Reuters) - Thermo Fisher Scientific:

* THERMO FISHER SCIENTIFIC - TO CO-DEVELOP A GLOBAL COMPANION DIAGNOSTIC FOR LOW-GRADE GLIOMA WITH AGIOS PHARMACEUTICALS

* THERMO FISHER - AGREEMENT WITH AGIOS CALLS FOR IDENTIFYING IDH GENE MUTATIONS USING ONCOMINE PRECISION ASSAY AND ION TORRENT GENEXUS SYSTEM

* THERMO FISHER SCIENTIFIC INC - WILL RETAIN RIGHTS TO COMMERCIALIZE TEST GLOBALLY UNDER DEAL WITH AGIOS

* THERMO FISHER SCIENTIFIC - WILL LEAD FILINGS TO SEEK CLEARANCE FROM APPROPRIATE REGULATORY AGENCIES UNDER DEAL WITH AGIOS PHARMACEUTICALS Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below